EMEA-002826-PIP01-20-M01

Key facts

Invented name
Veklury
Active substance
remdesivir
Therapeutic area
Infectious diseases
Decision number
P/0060/2021
PIP number
EMEA-002826-PIP01-20-M01
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of Coronavirus disease 2019
Route(s) of administration
Intravenous use
Contact for public enquiries
Gilead Sciences International Ltd

E-mail: regulatory.pip@gilead.com
Tel. +44 (0)1223 897300

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating